HEADER GENE REGULATION/INHIBITOR 10-JUL-18 6E1Y TITLE DISCOVERY OF POTENT 2-ARYL-6,7-DIHYDRO-5HPYRROLO[ 1,2-A]IMIDAZOLES AS TITLE 2 WDR5 WIN-SITE INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE- TITLE 3 BASED DESIGN COMPND MOL_ID: 1; COMPND 2 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WDR5, BIG3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WDR5, WIN-SITE, FRAGMENT SCREENING, STRUCTURE-BASED DESIGN, MIXED- KEYWDS 2 LINEAGE LEUKEMIA, DNA BINDING PROTEIN, DNA BINDING PROTEIN-INHIBITOR KEYWDS 3 COMPLEX, GENE REGULATION, GENE REGULATION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.PHAN,S.W.FESIK REVDAT 4 11-OCT-23 6E1Y 1 REMARK REVDAT 3 18-DEC-19 6E1Y 1 REMARK REVDAT 2 20-MAR-19 6E1Y 1 JRNL REVDAT 1 13-MAR-19 6E1Y 0 JRNL AUTH E.R.AHO,J.WANG,R.D.GOGLIOTTI,G.C.HOWARD,J.PHAN,P.ACHARYA, JRNL AUTH 2 J.D.MACDONALD,K.CHENG,S.L.LOREY,B.LU,S.WENZEL,A.M.FOSHAGE, JRNL AUTH 3 J.ALVARADO,F.WANG,J.G.SHAW,B.ZHAO,A.M.WEISSMILLER, JRNL AUTH 4 L.R.THOMAS,C.R.VAKOC,M.D.HALL,S.W.HIEBERT,Q.LIU, JRNL AUTH 5 S.R.STAUFFER,S.W.FESIK,W.P.TANSEY JRNL TITL DISPLACEMENT OF WDR5 FROM CHROMATIN BY A WIN SITE INHIBITOR JRNL TITL 2 WITH PICOMOLAR AFFINITY. JRNL REF CELL REP V. 26 2916 2019 JRNL REFN ESSN 2211-1247 JRNL PMID 30865883 JRNL DOI 10.1016/J.CELREP.2019.02.047 REMARK 2 REMARK 2 RESOLUTION. 1.22 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_3139: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.22 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 173380 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.182 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.0247 - 2.9368 0.97 12674 148 0.1487 0.1522 REMARK 3 2 2.9368 - 2.3314 0.98 12777 157 0.1540 0.1817 REMARK 3 3 2.3314 - 2.0368 0.97 12690 137 0.1548 0.1660 REMARK 3 4 2.0368 - 1.8506 0.96 12545 153 0.1594 0.1543 REMARK 3 5 1.8506 - 1.7179 0.96 12525 144 0.1688 0.1859 REMARK 3 6 1.7179 - 1.6167 0.95 12375 148 0.1710 0.1716 REMARK 3 7 1.6167 - 1.5357 0.95 12404 139 0.1769 0.2034 REMARK 3 8 1.5357 - 1.4689 0.95 12277 135 0.1926 0.2192 REMARK 3 9 1.4689 - 1.4123 0.94 12253 139 0.2013 0.2258 REMARK 3 10 1.4123 - 1.3636 0.93 12177 132 0.2121 0.2188 REMARK 3 11 1.3636 - 1.3209 0.93 12102 147 0.2236 0.2519 REMARK 3 12 1.3209 - 1.2832 0.92 11987 139 0.2362 0.2254 REMARK 3 13 1.2832 - 1.2494 0.89 11663 135 0.2525 0.2639 REMARK 3 14 1.2494 - 1.2189 0.84 10948 130 0.2747 0.3251 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.650 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4951 REMARK 3 ANGLE : 1.113 6733 REMARK 3 CHIRALITY : 0.093 750 REMARK 3 PLANARITY : 0.007 849 REMARK 3 DIHEDRAL : 18.108 1761 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6E1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1000235580. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 173496 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.219 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.22 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 6D9X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 6.0 OR HEPES PH 7.5, REMARK 280 0.2 M AMMONIUM ACETATE, 28% TO 32% PEG3350, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 465 THR A 24 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 PRO A 28 REMARK 465 THR A 29 REMARK 465 PRO A 30 REMARK 465 VAL A 31 REMARK 465 ILE A 210 REMARK 465 ASP A 211 REMARK 465 ASP A 212 REMARK 465 ASP A 213 REMARK 465 SER B 22 REMARK 465 ALA B 23 REMARK 465 THR B 24 REMARK 465 GLN B 25 REMARK 465 SER B 26 REMARK 465 LYS B 27 REMARK 465 PRO B 28 REMARK 465 THR B 29 REMARK 465 PRO B 30 REMARK 465 VAL B 31 REMARK 465 ASP B 211 REMARK 465 ASP B 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE ARG B 181 O HOH B 502 1.33 REMARK 500 HZ2 LYS B 109 O HOH B 503 1.38 REMARK 500 HE21 GLN A 204 O HOH A 504 1.38 REMARK 500 HZ1 LYS B 159 O HOH B 505 1.42 REMARK 500 HZ3 LYS B 296 O HOH B 511 1.55 REMARK 500 O HOH B 751 O HOH B 823 1.68 REMARK 500 O HOH B 868 O HOH B 874 1.82 REMARK 500 O HOH A 768 O HOH A 839 1.82 REMARK 500 O HOH A 718 O HOH A 786 1.85 REMARK 500 O HOH A 879 O HOH A 900 1.87 REMARK 500 O HOH A 598 O HOH A 801 1.87 REMARK 500 O HOH B 621 O HOH B 787 1.88 REMARK 500 OD2 ASP B 213 O HOH B 501 1.88 REMARK 500 O HOH A 833 O HOH A 873 1.89 REMARK 500 O HOH A 810 O HOH A 866 1.90 REMARK 500 O HOH A 554 O HOH A 884 1.92 REMARK 500 O HOH B 502 O HOH B 517 1.93 REMARK 500 NE ARG B 181 O HOH B 502 1.94 REMARK 500 O HOH B 757 O HOH B 787 1.94 REMARK 500 O HOH A 788 O HOH B 806 1.95 REMARK 500 OD1 ASN A 323 O HOH A 501 1.95 REMARK 500 O HOH B 743 O HOH B 786 1.96 REMARK 500 NZ LYS B 109 O HOH B 503 1.97 REMARK 500 O HOH A 605 O HOH A 721 1.98 REMARK 500 O HOH A 768 O HOH A 879 1.98 REMARK 500 O HOH A 527 O HOH A 760 1.98 REMARK 500 O HOH A 592 O HOH A 853 2.00 REMARK 500 O HOH A 783 O HOH A 863 2.00 REMARK 500 O HOH A 564 O HOH A 927 2.00 REMARK 500 O HOH B 600 O HOH B 700 2.00 REMARK 500 O PHE B 263 O HOH B 504 2.00 REMARK 500 O HOH A 510 O HOH A 868 2.04 REMARK 500 ND2 ASN A 323 O HOH A 502 2.04 REMARK 500 O HOH B 783 O HOH B 888 2.04 REMARK 500 O HOH A 528 O HOH A 877 2.04 REMARK 500 O HOH A 740 O HOH A 868 2.06 REMARK 500 O HOH A 800 O HOH A 835 2.07 REMARK 500 O HOH A 803 O HOH A 812 2.07 REMARK 500 O HOH A 564 O HOH A 727 2.08 REMARK 500 O HOH A 562 O HOH A 858 2.09 REMARK 500 NZ LYS B 159 O HOH B 505 2.10 REMARK 500 NH2 ARG B 181 O HOH B 506 2.11 REMARK 500 O HOH A 766 O HOH A 885 2.11 REMARK 500 O HOH A 527 O HOH A 884 2.13 REMARK 500 O HOH A 797 O HOH A 857 2.14 REMARK 500 O HOH B 624 O HOH B 633 2.15 REMARK 500 O HOH B 849 O HOH B 886 2.15 REMARK 500 O HOH A 844 O HOH A 909 2.16 REMARK 500 O HOH A 506 O HOH A 595 2.17 REMARK 500 OE2 GLU B 292 O HOH B 507 2.17 REMARK 500 REMARK 500 THIS ENTRY HAS 52 CLOSE CONTACTS REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 862 O HOH B 895 1455 1.93 REMARK 500 O HOH A 963 O HOH B 907 1554 2.03 REMARK 500 O HOH A 539 O HOH B 796 1565 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 181 CG - CD - NE ANGL. DEV. = -16.3 DEGREES REMARK 500 ARG B 181 NE - CZ - NH1 ANGL. DEV. = -4.7 DEGREES REMARK 500 ARG B 181 NE - CZ - NH2 ANGL. DEV. = 4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 67 4.45 82.89 REMARK 500 GLU A 151 4.28 80.95 REMARK 500 LEU A 234 37.83 -81.80 REMARK 500 LYS A 259 -43.19 -134.33 REMARK 500 LYS B 67 5.65 81.29 REMARK 500 GLU B 151 2.76 80.94 REMARK 500 LEU B 234 40.93 -80.09 REMARK 500 LYS B 259 -43.25 -130.47 REMARK 500 THR B 312 -30.55 -130.09 REMARK 500 ASP B 324 -64.56 -128.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HLM A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HLM B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6D9X RELATED DB: PDB DBREF 6E1Y A 22 334 UNP P61964 WDR5_HUMAN 22 334 DBREF 6E1Y B 22 334 UNP P61964 WDR5_HUMAN 22 334 SEQRES 1 A 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 A 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 A 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 A 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 A 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 A 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 A 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 A 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 A 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 A 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 A 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 A 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 A 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 A 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 A 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 A 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 A 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 A 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 A 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 A 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 A 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 A 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 A 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 A 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 A 313 CYS SEQRES 1 B 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 B 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 B 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 B 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 B 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 B 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 B 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 B 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 B 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 B 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 B 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 B 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 B 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 B 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 B 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 B 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 B 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 B 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 B 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 B 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 B 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 B 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 B 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 B 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 B 313 CYS HET HLM A 401 46 HET HLM B 401 46 HETNAM HLM N-[(1S)-1-(3-CHLOROPHENYL)ETHYL]-3-{[(4,5-DIHYDRO-1H- HETNAM 2 HLM IMIDAZOL-2-YL)AMINO]METHYL}BENZAMIDE FORMUL 3 HLM 2(C19 H21 CL N4 O) FORMUL 5 HOH *873(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N SER A 318 O LYS A 328 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O ALA A 61 N LYS A 52 SHEET 3 AA2 4 LEU A 68 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 SER A 84 -1 O ILE A 83 N ILE A 69 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O ALA A 105 N SER A 91 SHEET 3 AA3 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 CYS A 121 LYS A 126 -1 O LEU A 125 N LEU A 111 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O VAL A 145 N ASN A 136 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 CYS A 195 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 THR A 208 -1 O LEU A 206 N ILE A 197 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 TYR A 228 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LEU A 249 N LEU A 240 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O VAL A 275 N ASN A 265 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O VAL A 294 N ILE A 285 SHEET 1 AA8 4 ALA B 36 LEU B 41 0 SHEET 2 AA8 4 ILE B 327 LYS B 331 -1 O ILE B 327 N LEU B 41 SHEET 3 AA8 4 ILE B 315 ALA B 320 -1 N ILE B 316 O TRP B 330 SHEET 4 AA8 4 VAL B 304 CYS B 309 -1 N ALA B 308 O ALA B 317 SHEET 1 AA9 4 VAL B 48 PHE B 53 0 SHEET 2 AA9 4 TRP B 59 SER B 64 -1 O SER B 63 N SER B 49 SHEET 3 AA9 4 LEU B 68 GLY B 73 -1 O TRP B 72 N LEU B 60 SHEET 4 AA9 4 PHE B 79 SER B 84 -1 O GLU B 80 N ILE B 71 SHEET 1 AB1 4 ILE B 90 TRP B 95 0 SHEET 2 AB1 4 LEU B 101 SER B 106 -1 O VAL B 103 N ALA B 94 SHEET 3 AB1 4 THR B 110 ASP B 115 -1 O TRP B 114 N LEU B 102 SHEET 4 AB1 4 CYS B 121 LYS B 126 -1 O LEU B 125 N LEU B 111 SHEET 1 AB2 4 VAL B 132 PHE B 137 0 SHEET 2 AB2 4 LEU B 143 SER B 148 -1 O VAL B 145 N ASN B 136 SHEET 3 AB2 4 VAL B 153 ASP B 157 -1 O TRP B 156 N ILE B 144 SHEET 4 AB2 4 CYS B 163 LEU B 167 -1 O LEU B 167 N VAL B 153 SHEET 1 AB3 4 VAL B 174 PHE B 179 0 SHEET 2 AB3 4 LEU B 185 SER B 190 -1 O VAL B 187 N HIS B 178 SHEET 3 AB3 4 CYS B 195 ASP B 199 -1 O TRP B 198 N ILE B 186 SHEET 4 AB3 4 CYS B 205 LEU B 209 -1 O LEU B 209 N CYS B 195 SHEET 1 AB4 4 VAL B 217 PHE B 222 0 SHEET 2 AB4 4 TYR B 228 THR B 233 -1 O LEU B 230 N LYS B 221 SHEET 3 AB4 4 THR B 237 ASP B 242 -1 O TRP B 241 N ILE B 229 SHEET 4 AB4 4 LYS B 247 TYR B 252 -1 O LYS B 247 N ASP B 242 SHEET 1 AB5 4 ALA B 264 SER B 267 0 SHEET 2 AB5 4 TRP B 273 SER B 276 -1 O VAL B 275 N ASN B 265 SHEET 3 AB5 4 VAL B 283 ASN B 287 -1 O TYR B 284 N SER B 276 SHEET 4 AB5 4 ILE B 293 LEU B 297 -1 O LEU B 297 N VAL B 283 SITE 1 AC1 13 SER A 49 SER A 91 PHE A 133 PHE A 149 SITE 2 AC1 13 PRO A 173 SER A 175 LYS A 259 TYR A 260 SITE 3 AC1 13 CYS A 261 PHE A 263 ILE A 305 HOH A 576 SITE 4 AC1 13 HOH A 781 SITE 1 AC2 11 SER B 49 SER B 91 PHE B 133 PRO B 173 SITE 2 AC2 11 SER B 175 LYS B 259 TYR B 260 CYS B 261 SITE 3 AC2 11 PHE B 263 ILE B 305 HOH B 542 CRYST1 46.971 61.573 64.668 110.47 91.22 112.27 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021290 0.008718 0.004150 0.00000 SCALE2 0.000000 0.017550 0.007360 0.00000 SCALE3 0.000000 0.000000 0.016772 0.00000